Literature DB >> 644557

Anticoagulant activities of lung and mucous heparins.

T W Barrowcliffe, E A Johnson, C A Eggleton, D P Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 644557     DOI： 10.1016/0049-3848(78)90082-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

1.  [Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].

Authors:  J Harenberg; C Giese; A Knödler; R Zimmermann; G Schettler
Journal:  Klin Wochenschr       Date:  1986-11-17

2.  An evaluation of the British Pharmacopoeial assay of heparin: a comparison with other methods.

Authors:  G A Shah; T Z Dhall; I Ferguson; M R Davis; D T Graham; A R Pomeroy; D P Dhall
Journal:  J Clin Pathol       Date:  1980-06       Impact factor: 3.411

3.  Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.

Authors:  V V Kakkar; B Djazaeri; J Fok; M Fletcher; M F Scully; J Westwick
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-06

Review 4.  Clinical pharmacokinetics of heparin.

Authors:  J W Estes
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

5.  Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs.

Authors:  Ana M F Tovar; Gustavo R C Santos; Nina V Capillé; Adriana A Piquet; Bianca F Glauser; Mariana S Pereira; Eduardo Vilanova; Paulo A S Mourão
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.